TUESDAY 26 SEPTEMBER
NMS-001 – Phytopharmacological Investigation of Cissampelos pareira Linn. for Anti-inflammatory Potential
Prof Deepak Prabhakar Bhagwat1
1Panipat Institute Of Engineering And Technology, Pattikalyana,G.T. Road., Samalkha, Haryana-132102, India, Samalkha, India
NMS-002 Ivermectin effects on interleukin-6 induced nuclear translocation of STAT3 in a macrophage based cell line
Associate Professor Peter Cabot1, Sona Daniel1, Rayana Alawie1
1School of Pharmacy, Pharmacy Australia Centre of Excellence, The University Of Queensland, Woolloongabba, Australia
NMS-003 The therapeutic role of colchicine in vascular smooth muscle cell pathogenesis of atherosclerosis
Ms Sanchia M. Malapitan1, Mr Zheng J Chia1,2, Ms Hirushi Kumarapperuma1,2, Emeritus Professor Peter J Little1, Dr. Danielle Kamato1,2
1School of Pharmacy, Pharmacy Australia Centre of Excellence, The University of Queensland, Woolloongabba, Queensland 4102, Australia, 2Griffith Institute for Drug Discovery, Griffith University, Nathan, Queensland 4111, Australia
NMS-004 Cytotoxicity on MDA-MB-231 cells and antioxidant activity of tibig (Ficus nota Blanco Merr.)
Mr Reysan Cosas1, Dr Maricar Ching
1Centro Escolar University, Manila, Philippines
NMS-005 Multinational medical cannabis use patterns for mental and physical health conditions and pharmacy practice considerations
Myfanwy Graham1, 2, Alexandra Fotini Kritikos2, Ms Wayne Hall3, Rosalie Pacula2, David Hammond4
1The University of Newcastle (UON), Callaghan, Australia, 2University of Southern California, Los Angeles, United States, 3University of Queensland, Brisbane, Australia, 4University of Waterloo, Waterloo, Canada
NMS-006 Isolation and characterisation of andrographolide from andrographis paniculata and investigation of its interleukin-6 inhibitory activity
Dr. Sandra Megantara Hermawan1, Dr. Ida Musfiroh1, Dr Rimadani Pratiwi1, Prof Nasrul Wathoni2, Cecep Suhandi2, Dr. Mayada Fouad Abdel Wahab3, Dr. Ahmed Fouad Abdel Wahab4, Dr. Dwintha Lestari5
1Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia, 2Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia, 3Department of Pharmacognosy, Faculty of Pharmacy, Minia University, Minia, Egypt, 4Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, Egypt, 5Department of Pharmacy, Faculty of Science and Technology, Universitas Muhammadiyah Bandung, Bandung, Indonesia
NMS-007 Can the peptide Nisin be used to kill Gram-negative bacteria?
Dr Rebecka Isaksson1, Professor Alethea Tabor2, Dr Gorjan Stojanovski2, Dr Jack Jeffries2
1UCL School of Pharmacy, London, United Kingdom, 2UCL Department of Chemistry, London, United Kingdom
NMS-008 Comparative antidiabetic effect of the aqueous methanol extract of Annona Muricata L. (annonaceae) leaves and fruits on alloxan-induced diabetic albino rats
Ms Godsgift Iwendi1, Pharm Elechi N.A.1
1Faculty of Pharmaceutical Sciences, University of Port Harcourt, Nigeria, Rivers State, Nigeria
NMS-009 Cytotoxicity and apoptosis mechanism of ethyl acetate extract of helminthostachys zeylanica on MCF-7 breast cancer cell line
Dr Pinus Jumaryatno1, Annisa Fitria1, Inesya Reyadillah Nurdin1, Rengganis Ulvia1
1Department of Pharmacy, Universitas Islam Indonesia, Daerah Istimewa Yogyakarta, Indonesia
NMS-010 Vasorelaxant effect of ethyl acetate fraction of Hydrocotyle Javanica Thunb and its mechanism in spontaneously hypertensive rats aortic ring.
Ms Rusdiah Ruzanna Jusoh1, Dr. Aidiahmad Dewa, Ms. Nadiah Razali, Ms. Nurul Maizan Manshor
1Manipal University College Malaysia, Melaka, Malaysia, 2Universiti Sains Malaysia, Penang, Malaysia
NMS-011 Modified synthesis of beta-amylid PET tracer [18F]FC-119S for our automated synthesizer
Prof Takuya Kumamoto1, Jun Ogura2, Makoto Funasaka2, Eiko N. Minakawa2, Kazuhiko Seki2, Dr Koichi Kato2
1Hiroshima University, Hiroshima, Japan, 2National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan
NMS-012 Discovery of novel quinoline derivatives as potent POLRMT inhibitors for the treatment of cancer
Dr. Xinnan Li, Prof. Hong Yao, Prof. Jinyi Xu, Prof. Chunyong Wu
1China Pharmaceutical University, Nanjing, China
NMS-013 Dotinurad treatment for hyperuricemia in patients with non-dialysis chronic kidney disease
Prof Akira Mima1
1Osaka Medical And Pharmaceutical Univ., Takatsuki, Japan
NMS-014 Evaluation of the therapeutic effect and safety of REGKIRONA(Regdanvimab)
Mr Ya Moon1, Ms Junghyun Lim, Ms Nayoung Kim, Ms Minhyung Kim, Ms Soyoung Baeg, Ms Hyokeun Jeong
1Department of Pharmacy, Veterans Helth Service medical center, Seoul, South Korea
WEDNESDAY 27 SEPTEMBER
NMS-020 Development of Swietenia mahagoni seed as safe anti-diabetic adjuvant: a preclinical evaluation
Dr Y P Naveen1, Ms M Tanushree1, Mr B K Byresh Gowda1, Professor K Byrappa1
1Center for Research and Innovation, School of Natural Sciences, Adichunchanagiri University, BG Nagara, India
NMS-021 Effect of oleanolic acid on ischemic heart failure
Ming Qian
1Nanjing Drum Tower Hospital, Nanjing, china
NMS-022 Bivalent kappa acting opioid peptide constructs improves the stability while maintaining efficacy in kappa opioid receptor activity
Mr Danial Saifuddin1, Dr Rink-Jan Lohman1, Dr Karnaker Tupally1, Dr Harendra Parekh1, Assoc. Prof. Peter Cabot1
1UQ School of Pharmacy, Woolloongabba, Australia
NMS-023 Liraglutide combined three-dimensional cell therapy: the potential on improving cell transplantation therapy for nerve repair
Dr Yu-Ting Tseng1, Dr Mo Chen1, Dr Ju Jin1, Dr Andrea Standke1, Ms Francesca Oieni1, Assoc Prof Jenny Ekberg1, Prof James St John1
1Griffith University, Gold Coast, Australia
NMS-024 LL1, a novel small molecule inhibitor, overcomes oxaliplatin resistance in colorectal cancer by targeting STAT3 signaling and crosstalk with tumor-associated macrophages
先生 Like Xie1, Prof Jianguo Sun1
1China Pharmaceutical University, Nanjing, China
NMS-025 Discovery of Novel ALK Degraders Based on the Hydrophobic Tagging Technique
Dr Shaowen Xie1, Mr. Jingjie Zhu, Dr Shengtao Xu, Prof. Jinyi Xu
1China Pharmaceutical University, Nanjing, China
NMS-026 Silybin inhibits hepatocytes to produce and secrete succinate to reverse liver fibrosis
Dr Yuan Xie1, Xule Yang, Yunge Lou, Huan Li, Guangji Wang
1China Pharmaceutical University, Nanjing , China
NMS-027 Development of highly potent AKR1C3 inhibitors to restore the chemosensitivity of drug-resistant breast cancer
Mr Shuaishuai Xing1, Dr Haopeng Sun2
1China Pharmaceutical University, Nanjing, China, 2China Pharmaceutical University, Nanjing, China
NMS-028 Discovery of Novel NLRP3 Inflammasome Inhibitors by an In-house Database Driven Identification from Natural Product Oridonin
Dr. Chen He, Prof. Hong Yao, Prof. Shengtao Xu, Prof. Jinyi Xu
1China Pharmaceutical University, Nanjing, China
NMS-029 Wogonin alleviates inflammation and oxidative stress in acute lung injury via targeting PPARα
Dr Hui Yang1, Miss Yunran Hu2
1Affiliated Drum Tower Hospital Of Nanjing University Medical School, Nanjing, China, 2China Pharmaceutical University Nanjing Drum Tower Hospital, Nanjing, China
NMS-030 Impact of PCSK9 inhibitors on platelet reactivity among patients undergoing primary percutaneous coronary intervention
Ms Yao Yao1, Prof Xiaoye Li1, Dr Zi Wang1, Mr Shikun Xu1, Prof Qianzhou Lv1
1Zhongshan Hospital, Fudan University, Shanghai, China
NMS-031 Genistein prevents cigarette smoke-induced airway inflammation and oxidative stress in cells and rats by modulating cAMP/PKA/NFκB signaling
Prof Peng Zhang1, Prof Wenbing Gao1, Prof Zhishan Zhu1, Prof Weiling Cao1
1Shenzhen Luohu People’s Hospital, Shenzhen, China
NMS-032 The oncogenic role of cyclin-dependent kinase inhibitor 2C in lower-grade glioma
Dr Qiong-ni Zhu1, Dr Lei Hu2, Mr. Zhimin Zhu3
1Ruijin Hospital, Shanghai Jiao Tong University School Of Medicine, Shanghai, China, 2Peking University People’s Hospital, Beijing, China, 3Shanghai Eighth People’s Hospital, Shanghai, China
